Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi

Baltacı D; Adem Karaca; Mehmet Soytürk; Meltem Seymen; Mehmet Halis Tanrıverdi

Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi

Year 2010, Volume: 2 Issue: 1, 32 - 34, 01.04.2010

Baltacı D Adem Karaca Mehmet Soytürk Meltem Seymen Mehmet Halis Tanrıverdi

Keywords

Krom Pikolinat, Karaciğer Toksisitesi, Reçetesiz ilaç, Kaşıntı

References

1. Ghosh D, Bhattacharya B, Mukherjee B et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus. Nutr Biochem 2002;13(11):690-697.
2. Berner TO, Murphy MM, Slesinski R. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food Chem Toxicol 2004;42(6):1029-1042.
3. Anderson RA, Polansky MM, Bryden NA et al. Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables. Metabolism 1983;32:894-899.
4. Jeejeebhoy KN. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev 1999;57(11):329-335.
5. Vincent JB. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med 2003;33(3):213-230.
6. Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus- a review. Diabetes Technol Ther 2006;8(6):677-687.
7. Lamson DS, Steven MP. The safety and efficacy of high-dose chromium. Altern Med Rev 2002;7(3):218- 235.
8. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology. 2002;180(1):5-22.
9. Press RI, Geller J, Evans GW. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med 1990;152: 41-45.
10. Martin WR, Fuller RE. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998;18:860-862.
11. Wasser WG, Feldman NS, DíAgati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med 1997;126:410.
12. Cerulli J, Grabe DW, Gauthier I et al. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-431.

Year 2010, Volume: 2 Issue: 1, 32 - 34, 01.04.2010

Baltacı D Adem Karaca Mehmet Soytürk Meltem Seymen Mehmet Halis Tanrıverdi

References

1. Ghosh D, Bhattacharya B, Mukherjee B et al. Role of chromium supplementation in Indians with type 2 diabetes mellitus. Nutr Biochem 2002;13(11):690-697.
2. Berner TO, Murphy MM, Slesinski R. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food Chem Toxicol 2004;42(6):1029-1042.
3. Anderson RA, Polansky MM, Bryden NA et al. Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables. Metabolism 1983;32:894-899.
4. Jeejeebhoy KN. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev 1999;57(11):329-335.
5. Vincent JB. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med 2003;33(3):213-230.
6. Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus- a review. Diabetes Technol Ther 2006;8(6):677-687.
7. Lamson DS, Steven MP. The safety and efficacy of high-dose chromium. Altern Med Rev 2002;7(3):218- 235.
8. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology. 2002;180(1):5-22.
9. Press RI, Geller J, Evans GW. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West J Med 1990;152: 41-45.
10. Martin WR, Fuller RE. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998;18:860-862.
11. Wasser WG, Feldman NS, DíAgati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med 1997;126:410.
12. Cerulli J, Grabe DW, Gauthier I et al. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-431.

There are 12 citations in total.

Details

Primary Language	Turkish
Journal Section	Articles
Authors	Baltacı D This is me Adem Karaca This is me Mehmet Soytürk This is me Meltem Seymen This is me Mehmet Halis Tanrıverdi This is me
Publication Date	April 1, 2010
Published in Issue	Year 2010 Volume: 2 Issue: 1

Cite

APA	D, B., Karaca, A., Soytürk, M., Seymen, M., et al. (2010). Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi. Konuralp Medical Journal, 2(1), 32-34.
AMA	D B, Karaca A, Soytürk M, Seymen M, Tanrıverdi MH. Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi. Konuralp Medical Journal. April 2010;2(1):32-34.
Chicago	D, Baltacı, Adem Karaca, Mehmet Soytürk, Meltem Seymen, and Mehmet Halis Tanrıverdi. “Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi”. Konuralp Medical Journal 2, no. 1 (April 2010): 32-34.
EndNote	D B, Karaca A, Soytürk M, Seymen M, Tanrıverdi MH (April 1, 2010) Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi. Konuralp Medical Journal 2 1 32–34.
IEEE	B. D, A. Karaca, M. Soytürk, M. Seymen, and M. H. Tanrıverdi, “Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi”, Konuralp Medical Journal, vol. 2, no. 1, pp. 32–34, 2010.
ISNAD	D, Baltacı et al. “Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi”. Konuralp Medical Journal 2/1 (April 2010), 32-34.
JAMA	D B, Karaca A, Soytürk M, Seymen M, Tanrıverdi MH. Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi. Konuralp Medical Journal. 2010;2:32–34.
MLA	D, Baltacı et al. “Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi”. Konuralp Medical Journal, vol. 2, no. 1, 2010, pp. 32-34.
Vancouver	D B, Karaca A, Soytürk M, Seymen M, Tanrıverdi MH. Krom Pikonilat Alımından Kaynaklanan Karaciğer Toksitesi. Konuralp Medical Journal. 2010;2(1):32-4.